Nabriva Therapeutics plc reports

Company location: Dublin, Ireland
Fiscal year end: 31 December

Nabriva Therapeutics plc has filed 695 SEC EDGAR filings since 14 May 2015

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
20-F
6-K

SEC filing history

Showing 626-650 of 695 matching filings.

Per page

Current page

3

Filing date: 30 Dec 2016
Reporting date: 30 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

3

Filing date: 30 Dec 2016
Reporting date: 30 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 20 Dec 2016
Reporting date: 19 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

424B3 File 333-214197

424B3

Filing date: 15 Dec 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 15 Dec 2016
Reporting date: 15 Dec 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

FWP File 333-214197

FWP

Filing date: 15 Dec 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 29 Nov 2016
Reporting date: 29 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-214197

424B5

Filing date: 29 Nov 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 29 Nov 2016
Reporting date: 29 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 22 Nov 2016
Reporting date: 22 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 16 Nov 2016
Reporting date: 16 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 14 Nov 2016
Reporting date: 14 Nov 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-214197

EFFECT filing

Filing date: 09 Nov 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 07 Nov 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

F-3/A File 333-214197

F-3/A

Filing date: 04 Nov 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 02 Nov 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

F-3 File 333-214197

F-3

Filing date: 21 Oct 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 21 Oct 2016
Reporting date: 21 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 17 Oct 2016
Reporting date: 17 Oct 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 29 Aug 2016
Reporting date: 29 Aug 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 09 Aug 2016
Reporting date: 09 Aug 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-89113

SC 13G

Filing date: 29 Jul 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 25 Jul 2016
Reporting date: 25 Jul 2016
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89113

SCHEDULE 13G/A FOR NABRIVA THERAPEUTICS AG BY THE WELLCOME TRUST LIMITED

Filing date: 10 May 2016
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

6-K File 001-37558

6-K

Filing date: 10 May 2016
Reporting date: 10 May 2016
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing